摘要
目的:分析绵阳市游仙区2019~2021年新报告艾滋病病毒感染者/艾滋病患者(HIV/AIDS)首次检测T淋巴细胞计数结果,为当地艾滋病防治提供依据。方法:通过回顾性分析研究252例新报告HIV/AIDS患者的CD^(+)_(3)T淋巴细胞(CD 3)、CD^(+)_(4)T淋巴细胞(CD 4)、CD^(+)_(8)T淋巴细胞(CD 8)检测结果,对不同时间、不同性别、不同年龄段患者的检测结果进行分析。结果:CD 3、CD 4、CD 8检测结果均较低。不同时间及不同性别HIV/AIDS病例CD^(+)_(3)、CD^(+)_(4)、CD^(+)_(8)检测结果均值无差异(均P>0.05),不同年龄CD 3、CD 4、CD^(+)_(8)检测结果均值存在差异(均P<0.05),>45岁病例均值最低。CD 4均值较低,主要集中在<500个/μL的范围。CD 4≤200个/μL的比例在历年来以及不同性别人群无差异(χ^(2)=0.454,0.256,均P>0.05),但不同年龄人群有差异(χ^(2)=12.474,P<0.05),在>45岁病例中占比最高。结论:绵阳市游仙区新报告HIV/AIDS患者T淋巴细胞计数均值低,晚发比例高,尤其>45岁人群。应加强该类人群的艾滋病宣教及健康筛查,并按要求及时治疗。
Objective:To analyze the T lymphocytes count of newly reported HIV/AIDS patients from 2019 to 2021 in Youxian District,Mianyang City,so as to provide evidence for AIDS prevention and control in the city.Methods:The test results of patients in different time,sex and age were analyzed through retrospectively analyzing the tests of count level of CD+3 T lymphocytes,CD^(+)_(4)T lymphocytes and CD^(+)_(8)cytotoxic T lymphocytes(CTLs)of 252 newly reported HIV/AIDS patients.Results:A low count level of CD+3 T lymphocytes,CD^(+)_(4)T lymphocytes and CD8 were found.The difference of the mean values of CD 3,CD 4 and CD 8 in HIV/AIDS cases of different time and sex were not observable(P>0.05),but difference of the mean values of CD 3,CD 4 and CD 8 in different ages had statistical significance(P<0.05),and patients over 45 years old had the lowest mean values of the cases.The mean value of CD 4 count was relatively low,mainly below 500 cells/μL.The ratio of CD 4 count was below 200 cells/μL which had no statistically significant difference over the years and among different sex groups(χ^(2)=0.454,0.256,P>0.05),but differences among different age groups(χ^(2)=12.474,P<0.05)were observable,with the highest proportion in cases over 45 years old.Conclusions:The mean T lymphocytes count of newly reported HIV/AIDS patients in Youxian District,Mianyang City is low,with a high proportion of older patients,especially for people over 45 years old.Popularizing of AIDS prevention and HIV screening for these people should be strengthened,and timely treated as required.
作者
唐莹
肖辉
TANG Ying;XIAO Hui(Department of Clinical Laboratory,Youxian Center for Disease Control and Prevention,Mianyang 621000,China)
出处
《黑龙江医药科学》
2023年第1期84-86,共3页
Heilongjiang Medicine and Pharmacy